Adma Biologics Inc (ADMA) Live Share Price, Invest From India

Adma Biologics Inc Stock Performance

as on March 21, 2026 at 6:10 am IST

Day's Low
Day's High
$14.38
Day's Price Range
$15.22
$14.40
0.14%
Downside
5.69%
Upside
52 Week's Low
52 Week's High
$13.76
52-Week Price Range
$25.67
$14.40
4.44%
Downside
78.26%
Upside

Adma Biologics Inc share price movements today

Previous Close: $15.02
Open: $15.05
Volume: 2.2M
Day's Low - High: $14.38 - $15.22
52 Week Low - High: $13.76 - $25.67

Adma Biologics Inc Historical Returns

1 Month Return: -6.71 %
3 Month Return: -23.29 %
1 Year Return: -23.56 %
3 Year Return: + 387.66 %
5 Year Return: 0 %

Adma Biologics Inc Stock Fundamentals & Key Indicators

Check Adma Biologics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.6B

EPS (TTM)

1.04

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.53%

PE Ratio (TTM)

25.03

Industry PE ratio

7.891681415929203

PEG Ratio

EBITDA

199.5M

Revenue (TTM)

510.2M

Profit Margin

28.80%

Return On Equity TTM

35.56%

Adma Biologics Inc Stock Valuation

Track how Adma Biologics Inc P/E has moved over time to understand its valuation trends.

Adma Biologics Inc in the last 5 years

Overview
Trends

Lowest (-34.99x)

September 30, 2023

Industry (7.89x)

March 20, 2026

Today (25.03x)

March 20, 2026

Highest (59.92x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 25.03x

Adma Biologics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Adma Biologics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Adma Biologics Inc	BUY	$3.6B	NA	25.03	28.80%
Alnylam Pharmaceuticals, Inc.	BUY	$41.7B	115.8%	135.11	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$114.7B	111.95%	29.5	32.94%
Beone Medicines Ltd	NA	$32.4B	NA	114.75	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$78.7B	55.68%	17.95	31.41%

Stock Returns calculator for Adma Biologics Inc Stock including INR - Dollar returns

The Adma Biologics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Adma Biologics Inc investment value today

Current value as on today

₹81,829

Returns

₹18,171

(-18.17%)

Returns from Adma Biologics Inc Stock

₹26,718 (-26.72%)

Dollar Returns*

₹8,546 (+8.55%)

Analyst Recommendation on Adma Biologics Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Adma Biologics Inc. Average target price of $25.67

Adma Biologics Inc Share Price Target

Get share price movements and forecasts by analysts on Adma Biologics Inc.

What analysts predicted

43.9%UPSIDE

Target Price

$25.67

Current Price

$14.4

Analyzed by

10 Analysts

Target

$25.67

Adma Biologics Inc target price $25.67, a slight upside of 43.9% compared to current price of $14.4. According to 10 analysts rating.

Adma Biologics Inc Stock’s Investor Sentiment and Interest

Search interest for Adma Biologics Inc Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 19, 2026 to March 21, 2026

Change:8% versus previous 30 day period

Adma Biologics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	67	73	81	107	119	117	114	121	134	139
Gross Profit	24	31	39	57	59	63	61	67	75	88
Operating Income	8	14	21	39	39	38	34	42	51	62
EBITDA	11	-9	24	41	42	39	37	43	51	65
Interest Expense	6	6	3	3	3	2	1	1	1	1
Depreciation	2	2	2	2	1	1	1	2	2	2
Income Before Tax	2	-17	18	35	36	34	33	40	47	61
Income Tax Expense	6	0	0	3	0	-77	6	5	11	12
Net Income	2	-17	17	32	35	111	26	34	36	49
Net Profit Margin	3.81%	-23.88%	21.75%	29.91%	29.96%	95.19%	23.44%	28.05%	27.14%	35.48%

Adma Biologics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	10	22	16	29	42	80	154	258	426	510
Gross Profit	4	-6	-25	-10	-19	1	35	88	219	292
Operating Income	-17	-39	-60	-41	-64	-58	-39	21	138	191
EBITDA	-16	-39	-56	-36	-59	-53	-39	5	147	197
Interest Expense	2	3	5	8	11	13	19	25	13	7
Depreciation	-	2	3	3	3	5	7	8	8	8
Income Before Tax	-19	-43	-65	-48	-75	-71	-65	-28	125	182
Income Tax Expense	2	4	5	8	11	12	19	8	-71	35
Net Income	-19	-43	-65	-48	-75	-71	-65	-28	197	146
Net Profit Margin	-183.05%	-192.26%	-387.06%	-164.50%	-179.41%	-88.52%	-42.77%	-10.94%	46.35%	28.80%

Adma Biologics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-17	17	32	35	111	26	34	36	49
Operating Cash Flow	17	-2	45	25	50	-19	21	13	35
Investing Cash Flow	-1	-2	-2	-1	-2	-4	-2	-14	0
Financing Cash Flow	-38	-1	0	-25	-31	-7	0	-27	-9
Change in Cash	-22	-6	42	-1	16	-31	18	-28	26

Adma Biologics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-43	-65	-48	-75	-71	-65	-28	197	146
Operating Cash Flow	-37	-62	-76	-102	-112	-59	8	118	50
Investing Cash Flow	15	-2	-3	-12	-13	-13	-4	-8	-21
Financing Cash Flow	60	42	80	143	121	108	-38	-58	-44
Change in Cash	38	-21	0	29	-4	35	-35	51	-15

Global Institutional Holdings in Adma Biologics Inc

Funds	Holdings
Dimensional Fund Advisors, Inc.	2.03%
Franklin Resources Inc	1.19%
B Group, Inc	1.03%
Capital Research Global Investors	1.37%
Ranger Investment Management LP	0.97%

See all

Insights on Adma Biologics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ADMA has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, 26.90M → 49.37M (in $), with an average increase of 17.9% per quarter
POSITIVE IMPACT
Price Rise
In the last 3 years, ADMA stock has moved up by 387.7%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 114.80M → 139.16M (in $), with an average increase of 6.2% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 22.7% return, outperforming this stock by 46.3%

About Adma Biologics Inc

adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.

Organisation	Adma Biologics Inc
Headquarters	465 State Route 17, Ramsey, NJ, United States, 07446
Industry	Health Technology
CEO	Mr. Adam S. Grossman
E-voting on shares	Click here to vote

Key Management of Adma Biologics Inc

Name	Title
Ms. Kaitlin Kestenberg	COO & Senior VP of Compliance
Mr. Brad Tade	Consultant
Mr. P. Terence Kohler	CFO & Treasurer
Mr. Michael Goldstein	General Counsel
Mr. John Hafl	Executive Director of Sales
Mr. Skyler Bloom	Senior Director of Business Development & Corporate Strategy
Mr. Adam S. Grossman	Co-Founder, President, CEO & Director
Dr. Jerrold B. Grossman D.P.S., Ph.D.	Co-Founder & Vice Chairman of the Board

FAQs

What is Adma Biologics Inc share price today?

Adma Biologics Inc share price today is $14.4 as on March 21, 2026 at 12:40 am IST. Adma Biologics Inc share today touched a day high of $15.22 and a low of $14.38.

What is the 52 week high and 52 week low for Adma Biologics Inc share?

Adma Biologics Inc share touched a 52 week high of $25.67 on April 28, 2025 and a 52 week low of $13.76 on November 7, 2025. Adma Biologics Inc stock price today i.e. March 21, 2026 at 12:40 am IST is trending at $14.4,which is 43.90% down from its 52 week high and 4.65% up from its 52 week low.

What is Adma Biologics Inc's market capitalisation today?

Adma Biologics Inc market capitalisation is $0.00T as on March 21, 2026 at 12:40 am IST.

How to invest in Adma Biologics Inc Stock (ADMA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Adma Biologics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adma Biologics Inc Shares that will get you 0.1042 shares as per Adma Biologics Inc share price of $14.4 per share as on March 21, 2026 at 12:40 am IST.

What is the minimum amount required to buy Adma Biologics Inc Stock (ADMA) from India?

Indian investors can start investing in Adma Biologics Inc (ADMA) shares with as little as ₹93.708 or $1 (as of March 21, 2026 at 12:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹937.08 in Adma Biologics Inc stock (as per the Rupee-Dollar exchange rate as on March 21, 2026 at 12:40 am IST). Based on Adma Biologics Inc share’s latest price of $14.4 as on March 21, 2026 at 12:40 am IST, you will get 0.6944 shares of Adma Biologics Inc. Learn more about fractional shares .